ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Abarelix
C72H95ClN14O14
1416.1 g/mol
API

Abarelix

CAS183552-38-7
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Abarelix is an injectable gonadotropin-releasing hormone antagonist used as an active pharmaceutical ingredient. It is primarily employed in the manufacturing of medications for reducing testosterone levels in certain oncological conditions.

pharmaceutical raw material for oncology formulationscompound for hormone-dependent prostate cancer research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Abarelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.75

Iturelix

CAS112568-12-4

pharmaceutical raw material

ApplicationSame Use

Ganirelix

CAS123246-29-7

pharmaceutical raw material

ApplicationSame Use

Ganirelix

CAS124904-93-4

pharmaceutical raw material

ApplicationSame Use

Ganirelix acetate

CAS129311-55-3

pharmaceutical raw material

ApplicationSame Use

Cetrotide

CAS145672-81-7

pharmaceutical raw material

ReferenceSame Category

Befotertinib

CAS1835667-63-4

pharmaceutical raw material

ReferenceSame Category

Ethacridine lactate

CAS1837-57-6

pharmaceutical raw material

ReferenceSame Category

Formoterol fumarate dihydrate

CAS183814-30-4

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Customs Tariff Classification

The international HS code for Abarelix (CAS 183552-38-7) is 2937.19.

HS code (international, 6-digit)

2937.19

EU CN code (8-digit)

2937 19 00

Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.

Identifiers
IUPAC Name

(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]-methylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide

InChIKey

AIWRTTMUVOZGPW-HSPKUQOVSA-N

SMILES

C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C

Synonyms (21)
  • R-3827
  • R382
  • Abarelix (USAN/INN)
  • Abarelix
  • Abarelix Acetate
  • Abarelix-Depot-M
  • Plenaxis
  • Plenaxis (TN)
  • Plenaxis depot
  • R3827;PPI 149
  • abarelixum

Sourcing Abarelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→